N-(HETERO)ARYL-PYRROLIDINE DERIVATIVES OF PYRAZOL-4-YL-PYRROLO[2,3-D]PYRIMIDINES AND PYRROL-3-YL-PYRROLO[2,3-D]PYRIMIDINES AS JANUS KINASE INHIBITORS

THE PRESENT INVENTION RELATES TO N-(HETERO) ARYL-PYRROIIDIFLE DERIVATIVES OF FORMULA I, AS WELL AS THEIR COMPOSITIONS AND METHODS OF USE, WHICH ARE JAK INHIBITORS, SUCH AS SELECTIVE JAK1 INHIBITORS, USEFUL IN THE TREATMENT OF JAK-ASSOCIATED DISEASES INCLUDING, FOR EXAMPLE, INFLAMMATORY AND AUTOIMMUN...

Full description

Saved in:
Bibliographic Details
Main Authors SHEPARD, STACEY, WANG, HAISHENG, SHAO, LIXIN, RODGERS, JAMES D, FOLMER, BEVERLY, ZHU, WENYU, STORACE, LOUIS, ARVANITIS, ARGYRIOS G, GLENN, JOSEPH P
Format Patent
LanguageEnglish
Published 15.03.2016
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:THE PRESENT INVENTION RELATES TO N-(HETERO) ARYL-PYRROIIDIFLE DERIVATIVES OF FORMULA I, AS WELL AS THEIR COMPOSITIONS AND METHODS OF USE, WHICH ARE JAK INHIBITORS, SUCH AS SELECTIVE JAK1 INHIBITORS, USEFUL IN THE TREATMENT OF JAK-ASSOCIATED DISEASES INCLUDING, FOR EXAMPLE, INFLAMMATORY AND AUTOIMMUNE DISORDERS, AS WELL AS CANCER.
Bibliography:Application Number: MY2011PI05626